Drug Utilization Study Evaluating Additional Risk Minimisation Measures for Upadacitinib in the Treatment of Ulcerative Colitis in EuropeFirst published 16/01/2024 Last updated 23/04/2024 EU PAS number: EUPAS107885StudyPlannedDownload as PDF